|

Propranolol hydrochloride Clinical Trials

4 actively recruiting trials across 2 locations

Also known as: 2-Propanol, 1-[(1-methylethyl)amino]-3-(1- naphthalenyloxy)-, hydrochloride, Inderal, Propranolol

New York, New York2 trials

Beta-blocker Administration for Cardiomyocyte Division

Weill Cornell Medicine

Phase 1
Propranolol Treatment for Postoperative Chylothorax

Columbia University Irving Medical Center/NewYork-Presbyterian

Phase 1/2

Other1 trial

Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer
Phase 1

St Louis, Missouri1 trial

Propranolol for the Treatment of Kaposi Sarcoma in Adults

Washington University School of Medicine

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.